Inner Cosmos
Scotts Valley, US · Delaware corporation · 6 known investors
Inner Cosmos develops a minimally invasive brain-computer interface, described as a "digital pill," aimed at treating depression. The company has run an FDA-approved clinical trial for depression and publishes research on its neurotechnology.
Founders & leadership
MG
Meron GribetzExecutive Officer
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$1.9MraisedNov 2024 · 30 investors · Other TechnologyRule 506(b)
▶$1.9MraisedNov 2024 · 30 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Meron GribetzExecutive Officer
- Offering amount
- $6.3M
- Amount sold
- $1.9M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.